Similar articles

• Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis.

  Marra AR, Major Y, Edmond MB. Marra AR, et al. J Clin Microbiol. 2006 May;44(5):1915-6. doi: 10.1128/JCM.44.5.1915-1916.2006. J Clin Microbiol. 2006. PMID: 16672440 Free PMC article.
• Linezolid-resistant Enterococcus faecalis: first report in Spain.

  Sánchez-Gómez JC, Fraile-Malmierca F, Valverdé-Romero ED, Sánchez M, García-Rodríguez JA, García-Sánchez JE. Sánchez-Gómez JC, et al. J Chemother. 2006 Aug;18(4):440-2. doi: 10.1179/joc.2006.18.4.440. J Chemother. 2006. PMID: 17024804 No abstract available.
• Emergence of mutation-based linezolid-resistant invasive Enterococcus faecalis in a haemodialysis patient in Norway.

  Thilesen CM, Bjørang O, Skrede T, Aronsen T, Aasnaes B, Sundsfjord A, Hegstad K. Thilesen CM, et al. APMIS. 2014 Jan;122(1):83-4. doi: 10.1111/apm.12100. Epub 2013 May 8. APMIS. 2014. PMID: 23656533 No abstract available.
• Enterococcus faecalis resistant to linezolid: case series and review of the literature.

  Burleson BS, Ritchie DJ, Micek ST, Dunne WM. Burleson BS, et al. Pharmacotherapy. 2004 Sep;24(9):1225-31. doi: 10.1592/phco.24.13.1225.38086. Pharmacotherapy. 2004. PMID: 15460184 Review.
• In vitro activity of daptomycin against clinical isolates with reduced susceptibilities to linezolid and quinupristin/dalfopristin.

  Anastasiou DM, Thorne GM, Luperchio SA, Alder JD. Anastasiou DM, et al. Int J Antimicrob Agents. 2006 Nov;28(5):385-8. doi: 10.1016/j.ijantimicag.2006.07.017. Int J Antimicrob Agents. 2006. PMID: 17046205 Review.